Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD

ISIN: IE0009355771

Categoria Morningstar: Sector Equity Healthcare

Empresa: Janus Henderson Investors

The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.

Rentabilidade anual 1 ano 3 anos 5 anos Início 2024 2023 2022 2021 2020
Rentabilidade anual: Fundo 1 ano: 18,46 3 anos: 8,94 5 anos: 10,64 Início: 6,79 2024: 10,54 2023: 1,87 2022: 1,92 2021: 12,67 2020: 13,22
Rentabilidade anual: Categoria 1 ano: 7,14 3 anos: 2,80 5 anos: 8,23 Início: - 2024: 6,02 2023: -0,81 2022: -9,78 2021: 16,67 2020: 11,21
Rentabilidade anual: Percentil 1 ano: 11,00 3 anos: 35,00 5 anos: 18,00 Início:- 2024: 17,00 2023: 37,00 2022: 10,00 2021: 68,00 2020: 31,00
Risco Volatilidade Rácio de Sharpe Correlação Beta Alfa Tracking error Rácio de informação
Risco: 3 anos 1 Volatilidade: - 3 Rácio de Sharpe: - 5 Correlação: 91,85 Beta: 1,00 Alfa: -1,96 Tracking error: 6,00 Rácio de informação: -0,38
Fonte: Morningstar. Dados em euros. Categoria: Sector Equity Healthcare. Data: 2024-03-28
Fonte: Morningstar. Dados em euros. Categoria: Sector Equity Healthcare. Data: 2024-03-28